Cancer and society : a multidisciplinary assessment and strategies for action / Eric H. Bernicker, editor.
Bernicker, Eric H. editor.
2019
RC262
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Cancer and society : a multidisciplinary assessment and strategies for action / Eric H. Bernicker, editor.
ISBN 9783030058555 (electronic book)
3030058557 (electronic book)
9783030058548
3030058549
DOI https://doi.org/10.1007/978-3-030-05855-5
Published Cham, Switzerland : Springer, 2019.
Language English
Description 1 online resource (xiv, 178 pages) : illustrations
Other Standard Identifiers 10.1007/978-3-030-05855-5 doi
Call Number RC262
Dewey Decimal Classification 614.5/999
Summary While a number of books have looked at the intersection between human health in general and other topics, such as climate change or diet, this book focuses specifically on cancer as it impacts and is impacted by social justice issues. The massive explosion of research knowledge of cancer immunology and genomics is holding out great promise of therapeutic advances, yet other human actions—climate change, pollution, business decisions, advertising – are fostering health inequalities as well as increasing risks. Those involved in cancer care and research are in a unique position to let their experiences and knowledge inform the public, yet very often have not taken strong public roles when it comes to discussing issues surrounding tobacco, climate change and health risks, financial toxicity of treatments, and diet choices. Written by a multidisciplinary team of authors and for medical oncologists, cancer researchers, occupational health workers, and related medical students, residents, and fellows, this book encourages oncologists to address public health care and the societal issues associated with cancer risk. This volume discusses the overarching theme of environmental justice and oncology, focuses on business and cancer (such as clinical trials, drug development and profits, and global disparities), as well as animals and cancer.
Note Includes index.
Access Note Access limited to authorized users.
Digital File Characteristics text file PDF
Source of Description Online resource; title from PDF title page (SpringerLink, viewed March 13, 2019).
Added Author Bernicker, Eric H. editor.
Available in Other Form Print version: : 9783030058548
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Intro; Foreword; Preface; Contents; Contributors; Chapter 1: Tobacco and Social Justice; Introduction; The State of Worldwide Tobacco Use and the Extent of the Problem; The Legal Realm; Targeting Vulnerable Communities; Environmental Consequences of Growing Tobacco; E-Cigarettes; Tobacco and Ethics; References; Chapter 2: Climate Change and Cancer; Introduction; Climate Change, Pollution, and Lung Cancer; Wildfire Smoke; Inversions and Anthropogenic Air Pollution; Climate Change, Ultraviolet Radiation Exposure, and Skin Cancer

Cancer and Changes in the Quality and Quantity of Important Stable CropsConclusions; References; Chapter 3: Pollution, Cancer Risk, and Vulnerable Populations; Introduction; Vulnerable Populations and Cancer Prevention; Environmental Justice in a Changing Chemical Landscape; Pesticide Safety in Low-Resource Settings; Pesticide Exposure and Cancer Risk Among Farmers, Families, and Children; Focus on Ecuador: Working Through Sociopolitical Barriers to Treat Cancer Amidst a Battle Over Oil and Biodiversity in Ecuador's Amazon

Focus on Africa: The Challenge of Defining the Problem in Rwanda: Is Indoor Air Pollution a Health Hazard?Indoor Smoke/Secondhand Smoke Exposure; Conclusion; References; Chapter 4: Causes, Consequences, and Control of High Cancer Drug Prices; Cancer Drug Prices; Explanations for High Cancer Drug Prices; The Clinical Benefits and Economic Value of Cancer Drugs; The Role of the FDA; Effect of High Cancer Drug Prices on Patients; Controlling the Cost of Cancer Drugs; Negotiating Drug Prices; Biosimilars and Generics; Reducing Other Wasteful Practices

Academia or Public Involvement in Clinical TrialsRepurposing of Older/Cheaper Drugs; Academia-Led Non-inferiority Studies; Responsible Prescribing; A Note on LMICs; Conclusions; References; Chapter 5: Clinical Trials: Not for the  Poor and the Old; Introduction; Clinical Trial Participation; Significance; Costs; Generalizability; Rights; Benefit; Respect and Justice; Contributing Factors; Clinicians; Eligibility Criteria; Cost; Research Infrastructure; Patients; (Re)Solutions; Resolution; Immediate Action; Ongoing Action; Reduce, Refine, and Replace; Reduce; Refine; Replace; References

Chapter 6: Global Disparities: Can the World Afford Cancer?Introduction; Healthcare Expenditure and Cancer Care; Government Investment in Healthcare; Access to Cancer Medications, and Affordability of Cancer Care; Access to Radiation Therapy; Availability of Preventive Strategies; Improving Global Access to Cancer Care; Role of National Governments; Role of International Organizations and Trade Regulations; Generic and Biosimilar Medications; Alternative Strategies to Improve Access to Novel Therapies; Creating the Evidence Base for Reducing Drug Pricing; Conclusion; References

Browse Subjects

Show more subjects...

Statistics

from
to
Export